Number of Hours of Sleep and Risk of Stroke

Sleep duration (either short or long) affect the risk of stroke according to this recent analysis. We had visited a study published in JACC on the link between acute MI and sleep duration. This study appears to show similar results as regards sleep duration and stroke. 

Cantidad de horas de sueño y riesgo de stroke

The work prospectively included 79,881 men and women between 45 and 79 followed up until their first event (event or stroke) for mean 14.6 years. The study also looked into genetic polymorphisms identified with sleep duration obtained from a publicly available database (MEGASTROKE and the International Stroke Genetics Consortia).

Long sleep (>9 hours a day) was associated with increased total risk of stroke and ischemic stroke (HR 1.12 and 1.14, respectively), while short sleep (<7 hours a day) increased the risk of intracranial bleeding. 

These results replicate almost exactly the MI results, where sleeping over 9 hours a day or fewer than 6 hours a day increases MI risk by 20 to 30%.


Read also: Hours of Sleep and Myocardial Infarction Risk.


The genetic analysis was not that clear, opening the possibility of a casual association. Without question, we do not have enough information to recommend a number of hours of sleep a day as primary prevention strategy against MI or stroke.

Conclusion

This large prospective study associated long sleep with increased risk of total and ischemic stroke, while short sleep was associated to intracranial bleeding. 

Original Title: Sleep Duration and Stroke. Prospective Cohort Study and Mendelian Randomization Analysis.

Reference: Olga E. Titova et al. Stroke. 2020 Nov;51(11):3279-3285. doi: 10.1161/STROKEAHA.120.029902.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Chronic Thromboembolic Pulmonary Hypertension: Treatment Outcomes According to a Worldwide Registry

Chronic thromboembolic pulmonary hypertension (CTEPH) is a highly limiting condition that, despite its moderate incidence, significantly impacts patient prognosis and quality of life. The...

Contemporary Outcomes of Acute Limb Ischemia Endovascular Revascularization

Acute limb ischemia (ALI) is a vascular emergency with high mortality rate. It has been defined as a sudden occlusion of limb perfusion compromising...

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroSMR Registry: Edge-to-Edge Mitral Treatment with 5-Year Outcomes

Cardiomyopathies and left atrial enlargement can lead to secondary mitral regurgitation (SMR). This condition is associated with ventricular dysfunction, causing heart failure, hospitalization, and...

TricValve Transcatheter Bicaval Valve System for Severe Tricuspid Insufficiency: Events at One Year

TricValve is the first bicaval valve system to obtain CE-Mark approval. This device heterotopic device eliminates tricuspid insufficiency reflux into the venous system, reducing...

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...